Asthmapolis Receives $5,000,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    634 West Main Street Madison, WI 53703
  • Company Description
    Asthmapolis is dedicated to improving the management of asthma for patients and healthcare professionals. Despite advances in our understanding of the disease and the development of more effective medications, morbidity and mortality from asthma have not declined.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    With the funds, Asthmapolis will deliver new innovations and services for its comprehensive solution of sensors, leading mobile technology and personalized support, extending its reach to the more than 50 million people living with chronic respiratory disease in the United States today.
  • M&A Terms
  • Venture Investor
    The Social+Capital Partnership

Trending on Xconomy